Multidrug resistance (MDR) expression in chronic myelogenous leukemia (CML).

被引：0
|
作者：
Kantarjian, H [1 ]
Manshouri, T [1 ]
Talpaz, M [1 ]
OBrien, S [1 ]
Keating, M [1 ]
Cortes, J [1 ]
Pierce, S [1 ]
Andreeff, M [1 ]
Kornblau, S [1 ]
Albitar, M [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,HOUSTON,TX 77030
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2236 / 2236
页数：1
相关论文
共 50 条
  • [21] ESTABLISHMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) IN SCID MICE
    HOYLE, C
    NEGRIN, RS
    BLOOD, 1994, 84 (10) : A493 - A493
  • [22] IMMUNOLOGICAL EVALUATION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML)
    HESTER, JP
    MCCREDIE, KB
    FREIREIC.EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 180 - 180
  • [23] ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    BUCKNER, CD
    CLIFT, RA
    STORB, R
    THOMAS, ED
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 486 - 486
  • [24] Are there gender differences in multidrug resistance gene I (MDR1) expression in chronic lymphatic leukemia (CLL)?
    Steiner, H
    Polliack, A
    Fibach, E
    Rund, D
    BLOOD, 1996, 88 (10) : 951 - 951
  • [25] PARTICIPATION IN CHRONIC MYELOID LEUKEMIA (CML) IN APPEARANCE AND IMATINIB RESISTANCE OF MULTI-DRUG RESISTANCE(MDR)
    Nakagawa, Yasunori
    Kurata, Morito
    Suzuki, Kenshi
    Kitagawa, Masanobu
    ANNALS OF ONCOLOGY, 2010, 21 : 16 - 17
  • [26] Resistance to imatinib among patients in chronic phase (CP) of chronic myelogenous leukemia (CML) in clinical practice
    Davis, C.
    Sanders, L.
    Hirji, I.
    Oliveria, S.
    Willey, V. J.
    Phillips, S.
    Yood, M. Ulcickas
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] DIFFERENTIAL EXPRESSION OF A CHRONIC MYELOGENOUS LEUKEMIA (CML) DERIVED MESSENGER-RNA IN VARIOUS FORMS OF LEUKEMIA
    STELLRECHT, CM
    MARS, WM
    GONDO, H
    SAUNDERS, GF
    FASEB JOURNAL, 1988, 2 (04): : A402 - A402
  • [28] N-GAL expression correlates with disease status in chronic myelogenous leukemia (CML).
    Villalva, Claire
    Sorel, Nathalie
    Bonnet, Marie-Laure
    Guilhot, Francois
    Chornel, Jean-Claude
    Turhan, Ali G.
    BLOOD, 2006, 108 (11) : 279B - 279B
  • [29] With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells
    Chen, Jie-Ru
    Jia, Xiu-Hong
    Wang, Hong
    Yi, Ying-Jie
    Li, You-Jie
    ONCOLOGY REPORTS, 2017, 37 (05) : 2735 - 2742
  • [30] A MATHEMATICAL-MODEL OF CHRONIC MYELOGENOUS LEUKEMIA (CML), CHRONIC PHASE
    BOROK, R
    PREISLER, H
    BLOOD, 1994, 84 (10) : A629 - A629
12345